We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Nipro Corp (8086) - Financial and Strategic SWOT Analysis Review

Published: July 2019
Pages: 44
Code: 573FF6953FD6DAA0E5D30E47247123B3
Format: PDF
Publisher GlobalData
From Add to basket
$ 125.00
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, half-type kits among others. It offers contract manufacturing services of injection, oral and external use drug formulations. Nipro also provides glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass forming machinery; other parts of pharmaceutical packaging including rubber plugs; and glass bulbs for vacuum flasks. The company has sales offices in North America, South America, Europe, Asia and Africa. Nipro is headquartered in Osaka, Japan.
Nipro Corp Key Recent Developments
Jan 13,2018:

Additonal Information

  • of management policy announced by president Yoshihiko Sano of Nipro, delivered at the New Year’s Management Meeting on January 13, 2018

Companies Mentioned

Mitsubishi Tanabe Pharma Corp
Kyowa Kirin Co Ltd
Chugai Pharmaceutical Co Ltd
Asahi Kasei Medical Co Ltd
B. Braun Melsungen AG
Taiho Pharmaceutical Co Ltd
Maquet Holding BV & Co KG
Fresenius SE & Co KGaA
Terumo Corp

Reasons to buy

You get detailed information about the company and its operations to identify potential customers and suppliers. The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios. Gain key insights into the company for academic or business research. Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Note: Some sections may be missing if data is unavailable for the company
Add to basket
  • Table of Contents
  • Table of Contents
  • List of Tables
  • List of Figures
  • Section 1 - About the Company
  • Nipro Corp - Key Facts
  • Nipro Corp - Key Employees
  • Nipro Corp - Major Products and Services
  • Nipro Corp - History
  • Nipro Corp - Company Statement
  • Nipro Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
  • Section 2 – Company Analysis
  • Company Overview
  • Nipro Corp - Business Description
  • Business Segment: Medical Related
  • Overview
  • Performance
  • Business Segment: Other
  • Overview
  • Performance
  • Business Segment: Pharma Packaging
  • Overview
  • Performance
  • Business Segment: Pharmaceutical Related
  • Overview
  • Performance
  • Geographical Segment: America
  • Performance
  • Geographical Segment: Asia
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Japan
  • Performance
  • R&D Overview
  • Nipro Corp - Corporate Strategy
  • Nipro Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Nipro Corp - Strengths
  • Nipro Corp - Weaknesses
  • Nipro Corp - Opportunities
  • Nipro Corp - Threats
  • Nipro Corp - Key Competitors
  • Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Nipro Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • Nipro Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
  • Nipro Corp, Recent Deals Summary
  • Section 5 – Company’s Recent Developments
  • Jan 13, 2018: Summary of management policy announced by president Yoshihiko Sano of Nipro, delivered at the New Year’s Management Meeting on January 13, 2018
  • Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • List of Tables
  • Nipro Corp, Key Facts
  • Nipro Corp, Key Employees
  • Nipro Corp, Major Products and Services
  • Nipro Corp, History
  • Nipro Corp, Other Locations
  • Nipro Corp, Subsidiaries
  • Nipro Corp, Joint Venture
  • Nipro Corp, Key Competitors
  • Nipro Corp, Ratios based on current share price
  • Nipro Corp, Annual Ratios
  • Nipro Corp, Annual Ratios (Cont...1)
  • Nipro Corp, Annual Ratios (Cont...2)
  • Nipro Corp, Interim Ratios
  • Nipro Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • Nipro Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
  • Nipro Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • List of Figures
  • Nipro Corp, Performance Chart (2015 - 2019)
  • Nipro Corp, Ratio Charts
  • Nipro Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • Nipro Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019

Keywords
;